Shareholders’ Deficit (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
May 31, 2026 |
May 31, 2025 |
Feb. 28, 2026 |
|
| Stockholders’ Deficit [Line Items] | |||
| Common stock, shares authorized | 150,000,000 | 150,000,000 | |
| Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
| Intrinsic value | |||
| Common shares issued for cash | 751 | $ 848 | |
| Warrant [Member] | |||
| Stockholders’ Deficit [Line Items] | |||
| Intrinsic value | |||
| Common Stock [Member] | |||
| Stockholders’ Deficit [Line Items] | |||
| Common shares issued for services (in Shares) | 3,415,152 | ||
| Common shares issued for cash (in Shares) | 6,860,000 | 3,415,152 | |
| Common shares issued for cash | $ 1 | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|